81% of Surveyed Life Science Companies Compensate Clinical Investigators on a Per-Patient Basis
July 18, 2016 08:37 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 18, 2016) - A Cutting Edge Information benchmarking study found that across all surveyed drug companies, 81% pay their clinical investigators on a...
62% of Surveyed Pharma Companies Look to C-Suite for Final Sequencing Decisions
July 13, 2016 08:38 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 13, 2016) - Within pharmaceutical organizations, the ultimate responsibility for approving launch sequences among 62% of companies lies with C-level...
US Pharma Companies Plan to Increase Percentage of Electronic Documents to 76% by 2020
July 13, 2016 08:30 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 13, 2016) - A study published by Cutting Edge Information found that the goal for US pharmaceutical companies is to increase their percentage of...
90% of Surveyed Companies Have Dedicated a Team of Health Economics and Outcomes Research Specialists
July 11, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 11, 2016) - Among surveyed pharmaceutical companies, approximately 90% now have dedicated teams of health economics and outcomes research (HEOR)...
77% of Surveyed Pharma Companies Use Ad Hoc Launch Sequencing Committees Instead of Dedicated Teams
June 30, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 30, 2016) - While executing a new drug launch, 77% of surveyed pharmaceutical companies look to ad hoc launch sequencing groups rather than maintaining...
67% of Small Medical Device Companies Centralize Medical Affairs Teams
June 29, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 29, 2016) - A new study of large and mid-size medical device companies found a 50-50 split between centralized and decentralized structures. Surveyed...
61% of Interventional Studies Are Traditional Randomized Control Trails
June 28, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - A new study published by Cutting Edge Information discovered that 61% of interventional studies are traditional randomized control trials...
77% of Investigator-Initiated Trial Committees With Complete Voting Privileges Let High-Level Executives Make Final Decisions
June 28, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - Investigator-initiated trial (IIT) review committees are often small and contain individuals from a variety of backgrounds. Most...
80% of Surveyed Drug and Device Companies Outsource a Portion of Government Reimbursement Activities
June 22, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 22, 2016) - According to a benchmarking study by Cutting Edge Information, 80% of surveyed life sciences companies allocate some portion of their...
62% of C-Level Executives Dominate the Approval of Pharmaceutical Launch Sequences
June 17, 2016 08:38 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 17, 2016) - A new study published by Cutting Edge Information found that 50% of Top 10 and Top 50 firms turn to C-level executives when planning launch...